PhRMA Firms Will Disclose “Ghost Writers,” Give Credit For Journal Work

Manuscript writers and statisticians provided by drug sponsors to help present results from a clinical trial will be "recognized appropriately" as contributors to publications of the data, according to a draft policy paper on the ethics of clinical trials under development by the Pharmaceutical Research & Manufacturers of America